Daniela Rodriguez Rincon is a senior analyst at RAND Europe working in the area of health, research and innovation policy, with a particular interest in innovation for infectious diseases and global health. She is currently managing a project assessing industry contributions to the fight against antimicrobial resistance.
Rodriguez Rincon has worked across communicable and non-communicable disease topic areas. Some examples include a study for Roche on the factors affecting access to treatment for early breast cancer; work on the barriers to accessing testing and treatment for HIV for men who have sex with men in Europe and how these impact the epidemiology of the disease; a study on the availability and use of point-of-care testing (POCT) for infectious diseases in Europe; and case study examples on the use of electronic health records for infectious disease surveillance, and the implementation of electronic health records in general practice in Denmark.
Prior to joining RAND, Rodriguez Rincon completed an internship in the Department of Strategic Policy at the United Nations Joint Programme on HIV/AIDS (UNAIDS). She holds a Ph.D. in medicine (microbiology) from the University of Cambridge and an M.Sc. in medical microbiology from the London School of Hygiene and Tropical Medicine.